HCPLive Five at APA 2024

From the prospect of semaglutide and MDMA for substance use disorder to evolving research around personality disorders and OCD, here are 5 key topics from the annual psychiatric meeting.

Related Keywords

Toronto ,Ontario ,Canada ,New York ,United States ,Columbia University ,American ,Davangerep Devanand ,Johnm Oldham ,Campbellp Semaglutide ,Katharine Phillips ,Brian Barnett ,Kunzmannk Davangere Devanand ,Dermanc Katharine Phillips ,Rogers Mcintyre ,Dermanc Brian Barnett ,American Psychiatric Association Practice Guidelines ,Neurological Institute At Cleveland Clinic ,Behavioral Health ,Drug Administration ,Behavioral Sciences At Baylor College Of Medicine ,Advisory Committee Meeting To Review Therapy ,Dementia Drug Development ,Columbia University Medical Center ,Menninger Department Of Psychiatry ,American Psychiatric Association ,Weill Cornell Medical College ,University Of Toronto ,Annual Meeting ,Menninger Department ,Behavioral Sciences ,Baylor College ,Lykos Therapeutic ,Neurological Institute ,Cleveland Clinic ,Published December ,Published May ,Psychiatric Association Practice ,Personality Disorder ,Committee Meeting ,Assisted Therapy ,Psychedelics Fitting ,Various Treatments ,Traditional Approval ,Early Stage Alzheimer ,Published July ,Dementia Drug ,